BioWorld-International-2011-03-23
Genfit, Sanofi-Aventis Ink $54M Deal for Metabolic Disorders
Genfit, Sanofi-Aventis Ink $54M Deal for Metabolic Disorders
Extending a partnership that dates back to 1999, Genfit, of Lille, France, has inked an agreement with Sanofi-Aventis SA, of Paris, to pursue therapies for the treatment of metabolic disorders. (BioWorld International)

